Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: biochar

April 14, 2026 Environmental / Non-pharma applications

β-cyclodextrin-modified thermally oxidized biochar for efficient remediation of uranium-contaminated soil

The remediation of uranium-contaminated soil remains a persistent challenge in the field of environmental restoration. Herein, a novel β-cyclodextrin-modified thermally

Continue reading

January 13, 2026 Environmental / Non-pharma applications

Effect of Microplastics on Cu2+ Adsorption by β-cyclodextrin Modified Biochar

The pervasive co-existence of microplastics with other pollutants complicates the efficacy of adsorbents in water remediation. This study, therefore, investigates

Continue reading

July 25, 2025 Non-pharma applications

Special Issue “Wastewater Resourceization: Pioneering the Future of Sustainable Water”

The open access journal Water (ISSN 2073-4441, IF 3.0) announced a new Special Issue entitled “Wastewater Resourceization: Pioneering the Future

Continue reading

March 19, 2025 Environmental / Non-pharma applications

CD-containing membrane for high-efficiency, low-fouling extraction of microplastics and PCB 209 from synthetic landfill leachate

This research focused on the development of 9 advanced Dopamine/β-Cyclodextrin modified polyethersulfone (PES) membranes, incorporating a polymer-coated magnetic activated biochar-zeolite

Continue reading

October 3, 2024 Environmental / Non-pharma applications

Enhanced Denitrification in Constructed Wetlands with Low Carbon/Nitrogen Ratios: Insights into Reallocation of Carbon Metabolism Based on Electron Utilization

Constructed wetlands (CWs) are a promising method to treat effluent from wastewater treatment plants (WWTPs). However, low carbon/nitrogen (C/N) ratios

Continue reading

Recent Posts

  • FermenGIN: γ-Cyclodextrin Takes the Bitterness Out of Bioconverted Red Ginseng
  • New book on beta-cyclodextrin and its derivatives
  • Moon, Water and Powdered Alcohol? A Footnote from NASA’s Lunar Life Support Studies
  • Enhancing Sunscreens: HPβCD Improves Ferulic Acid Efficacy
  • Protein Folding with Ionic Liquids and β-CD

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (28)
  • Analysis (75)
  • CD as API (359)
  • CD derivatives (440)
  • Cosmetics and toilettry (55)
  • Diagnosis (15)
  • Drug delivery (824)
  • E-ducation (64)
  • Environmental (144)
  • Events (242)
  • Food (239)
  • Gene delivery (22)
  • Household products (6)
  • In Hungarian (4)
  • Life sciences (46)
  • Non-pharma applications (427)
  • Other industrial use (114)
  • Pharma applications (1,231)
  • Supramolecular systems (45)
  • Uncategorized (172)

Top Posts

  • FermenGIN: γ-Cyclodextrin Takes the Bitterness Out of Bioconverted Red Ginseng
  • 22nd International Cyclodextrin Symposium (ICS-22) in India
  • Scientific Program of ICS22 India
  • Christmas cake with cyclodextrin
  • Pharmaceutics 2027 conference
  • Cyclodextrins without holes are reality
  • 16th Central European Symposium on Pharmaceutical Technology (CESPT 2027)
  • Cyclarity Unveils First-Ever Clinical Data Demonstrating Excretion of Oxidized Cholesterol, at American Heart Association Vascular Discovery Scientific Sessions
  • Results of Phase III clinical trial on efficacy and safety of Adamgammadex
  • The Cyclodextrin Wall of Pride: Who Are the Top-Cited Cyclodextrin Scientists?

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,470 other subscribers
Loading Comments...